Question 1

Does Wells Fargo own AQST stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Wells Fargo holds 1,089,037 shares of AQST (Aquestive Therapeutics), worth $4.5M.

Question 2

How many shares of AQST does Wells Fargo own?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo holds 1,089,037 shares of AQST (Aquestive Therapeutics).

Question 3

What is Wells Fargo's AQST position worth?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo's AQST position is worth $4.5M.

Question 4

Is Wells Fargo buying or selling AQST?

Accepted Answer

In Q2 2026, Wells Fargo increased its AQST position by 54,393 shares (+5.3%).

Question 5

When did Wells Fargo first buy AQST?

Accepted Answer

Wells Fargo already held AQST in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.1M	+5.3%	$4.5M	0.0%	$4.16	28
2026-Q1	Decreased	1M	-12.9%	$4.3M	0.0%	$4.15	0
2025-Q4	Increased	1.2M	+804.6%	$7.7M	0.0%	$6.46	44
2025-Q3	Increased	131,386	+27.0%	$734,448	0.0%	$5.59	31
2025-Q2	Increased	103,431	+86.5%	$342,357	0.0%	$3.31	37
2025-Q1	Increased	55,452	+7.6%	$160,811	0.0%	$2.90	17
2024-Q4	Increased	51,522	+54.3%	$183,418	0.0%	$3.56	22
2024-Q3	Increased	33,392	+3.3%	$166,292	0.0%	$4.98	16

AQSTShowing 8 of 28 quarters

AQST
Showing 8 of 28 quarters